Publications

Update on the telavancin activity tested against European staphylococcal clinical isolates (2009-2010). by Mendes RE, Sader HS, Farrell DJ and Jones RN published in Diagn. Microbiol. Infect. Dis. 2011; 71 (1): 93-97

Comparative effects of carbapenems on bacterial load and host immune response in a Klebsiella pneumoniae murine pneumonia model. by Hilliard JJ, Melton JL, Hall L, Abbanat D, Fernandez J, Ward CK, Bunting RA, Barron A, Lynch AS and Flamm RK published in Antimicrob. Agents Chemother. 2011; 55 (2): 836-844

Quality control guidelines for Amphotericin B, itraconazole, posaconazole and voriconazole disk diffusion susceptibility tests on non-supplemented Mueller-Hinton Agar (CLSI M51-A document) of nondermatophyte filamentous fungi by Espinel-Ingroff A, Canton E, Fothergill A, Ghannoum M, Johnson L, Jones RN, Ostrosky-Zeichner L, Schell W, Gibbs DL, Wang A and Turnidge J published in J. Clin. Microbiol. 2011; 49 (7): 2568-2571

Analytical and clinical validation of novel real-time reverse transcriptase-polymerase chain reaction assays for the clinical detection of swine-origin H1N1 influenza viruses. by Duncan C, Guthrie JL, Tijet N, Elgngihy N, Turenne C, Seah C, Lau R, McTaggart L, Mallo G, Perusini S, Rebbapragada A, Melano R, Low DE, Farrell D and Guyard C published in Diagn. Microbiol. Infect. Dis. 2011; 69 (2):167-171

Longitudinal survey of carbapenem resistance and resistance mechanisms in Enterobacteriaceae and non-fermenters from the USA in 2007-09. by Davies TA, Marie Queenan A, Morrow BJ, Shang W, Amsler K, He W, Lynch AS, Pillar C and Flamm RK published in J. Antimicrob. Chemother. 2011; 66 (10): 2298-2307

Evolving trends in Streptococcus pneumoniae resistance: implications for therapy of community-acquired bacterial pneumonia. by Jones RN, Jacobs MR and Sader HS published in Int. J. Antimicrob. Agents 2010; 36 (3): 197-204

Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. by Johnson JR, Johnston B, Clabots C, Kushkowski MA and Castanheira M published in Clin. Infect. Dis. 2010; 51 (3): 286-294

Escherichia coli resistant to quinolones at a comprehensive cancer center. by Mihu CN, Rhomberg PR, Jones RN, Coyle E, Prince RA and Rolston KV published in Diagn. Microbiol. Infect. Dis. 2010; 67: 266-269

MIC quality control guidelines and disk diffusion test optimization for CEM-101, a novel fluoroketolide. by Jones RN, Ross JE, Rhomberg PR published in J. Clin. Microbiol. 2010; 48 (4): 1470-1473

Spectrum of activity, mutation rates, synergistic interactions, and the effects of pH and serum proteins for fusidic acid (CEM-102). by Biedenbach DJ, Rhomberg PR, Mendes RE and Jones RN published in Diagn. Microbiol. Infect. Dis. 2010; 66 (3): 301-307

Evaluation of the activity of fusidic acid tested against contemporary Gram-positive clinical isolates from the USA and Canada by Pfaller MA, Castanheira M, Sader HS, Jones RN published in Int. J. Antimicrob. Agents 2010; 35 (3): 282-287

Wild-type MIC distributions and epidemiologic cutoff values for the Echinocandins and Candida spp. by Pfaller MA, Boyken L, Hollis RJ, Kroeger J, Messer SA, Tendolkar S, Jones RN, Turnidge J and Diekema D published in J. Clin. Microbiol. 2010; 48 (1):52-56

Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: Results from an international surveillance study. by Jones RN, Mendes RE and Sader HS published in J. Antimicrob. Chemother. 2010; 65 (Suppl 4): iv17-iv31

Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States by Jacobs MR, Good CE, Windau AR, Bajaksouzian S, Biek D, Critchley I, Sader HS and Jones RN published in Antimicrob. Agents Chemother. 2010; 54 (6): 2716-2719

Determination of CEM-101 activity tested against clinical isolates of Neisseria meningitidis from a worldwide collection by Biedenbach DJ, Castanheira M, Jones RN published in Antimicrob. Agents Chemother. 2010; 54 (9): 4009-4011

Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Etest methods with the CLSI broth microdilution method for echinocandin susceptibility testing of Candida species by Pfaller MA, Castanheira M, Diekema DJ, Messer SA, Moet GJ, Jones RN published in J. Clin. Microbiol. 2010; 48 (5); 1592-1599

Telavancin activity against Gram-positive bacteria isolated from patients with skin and skin-structure infections. by Pfaller MA, Rhomberg PR, Sader HS, Mendes RE and Jones RN published in J. Chemother. 2010; 22 (5): 304-311

Antimicrobial characterisation of CEM-101 activity against respiratory tract pathogens, including multidrug-resistant pneumococcal serogroup 19A isolates. by Farrell DJ, Sader HS, Castanheira M, Biedenbach DJ, Rhomberg PR and Jones RN published in Int. J. Antimicrob. Agents 2010; 35 (6): 537-543

Antimicrobial susceptibility patterns of KPC-producing or CTX-M-producing Enterobacteriaceae. by Castanheira M, Sader HS and Jones RN published in Microb. Drug Resist. 2010; 16 (4): 1-5

Telavancin activity against Gram-positive bacteria isolated from respiratory tract specimens of patients with nosocomial pneumonia. by Pfaller MA, Mendes RE, Sader HS and Jones RN published in J. Antimicrob. Chemother. 2010; 65 (11): 2396-2404

Assessment of linezolid resistance mechanisms among Staphylococcus epidermidis causing bacteraemia in Rome, Italy. by Mendes RE, Deshpande LM, Farrell DJ, Spanu T, Fadda G and Jones RN published in J. Antimicrob. Chemother. 2010; 65 (11): 2329-2335

Comparison of 30-min and 3-h infusion regimens for imipenem/cilastatin and for meropenem evaluated by Monte Carlo simulation. by Lee LS, Kinzig-Schippers M, Nafziger AN, Ma L, Sorgel F, Jones RN, Drusano GL, Bertino Jr. JS published in Diagn. Microbiol. Infect. Dis. 2010; 68 (3): 251-258

Update on fusidic acid (CEM-102) tested against Neisseria gonorrhoeae and Chlamydia trachomatis. by Jones RN, Biedenbach DJ, Roblin PM, Kohlhoff SA and Hammerschlag MR published in Antimicrob. Agents Chemother. 2010; 54 (10): 4518-4519

Correlation of cefoxitin MICs with presence of mecA in Staphylococcus spp. by Swenson JM, Brasso WB, Ferraro MJ, Hardy DJ, Knapp CC, Lonsway D, McAllister S, Reller LB, Sader HS, Shortridge D, Skov R, Weinstein MP, Zimmer BL, Patel published in J. Clin. Microbiol. 2009; 47 (6): 1902-1905

Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respirator tract and skin and skin structures, including recent pharmacodynamic considerations. by Biedenbach DJ and Jones RN published in Diagn. Microbiol. Infect. Dis. 2009; 64 (2):202-212

Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: Coping with antimicrobial susceptibility in an era of resistance. by Weinstein MP, Klugman KP and Jones RN published in Clin. Infect. Dis. 2009; 48 (11): 1596-1600

Potency and bactericidal activity of iclaprim against Gram-positive isolates. by Sader HS, Fritsche TR and Jones RN published in Antimicrob. Agents Chemother. 2009; 53 (5): 2171-2175

Antimicrobial activities of doripenem and other carbapenems against Pseudmonas aeruginosa, other nonfermentative bacilli, and Aeromonas spp. by Castanheira M, Jones RN, Livermore DM published in Diagn. Microbiol. Infect. Dis. 2009; 63 (4): 426-433

Antimicrobial activity of daptomycin and selected comparators tested against bloodstream Staphylococcus aureus isolates from hemodialysis patients. by Sader HS, Fritsche TR, Jones RN published in Int. J. Infect. Dis. 2009; 13 (2): 291-295

Carbapenem resistance among Pseudmonas aeruginosa strains form India: Evidence for nationwide endemicity of multiple metallo-beta-lactamase clones (VIM-2, -5, -6, and -11 and the newly characterized VIM-18). by Castanheira M, Bell JM, Turnidge JD, Mathai D and Jones RN published in Antimicrob. Agents Chemother. 2009; 53 (3): 1225-1227

Antimicrobial activity of prulifloxacin tested against a worldwide collection of gastroenteritis-producing pathogens, including those causing traveler’s diarrhea. by Fritsche TR, Biedenbach DJ and Jones RN published in Antimicrob. Agents Chemother. 2009; 53 (3): 1221-1224

Codetection of bla_OXA-23-like gene (bla_OXA-133) and bla_OXA-58 in Acintobacter radioresistens: Report from the SENTRY Antimicrobial Surveillance Program. by Mendes RE, Bell JM, Turnidge JD, Castanheira M, Deshpande LM and Jones RN published in Antimicrob. Agents Chemother. 2009; 53 (2): 843-844

Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates. by Biedenbach DJ, Bell JM, Sader HS, Turnidge JD and Jones RN published in Antimicrob. Agents Chemother. 2009; 53 (3): 1260-1263

A global evaluation of voriconazole activity tested against recent clinical isolates of Candida spp. by Diekema DJ, Messer SA, Hollis RJ, Boyken L, Tendolkar S, Kroeger J, Jones RN and Pfaller MA published in Diagn. Microbiol. Infect. Dis. 2009; 233 (2): 233-236

Summary trends for the Meropenem Yearly Susceptibility Test Information Collection Program: a 10-year experience in the United States (1999-2008) by Rhomberg PR and Jones RN published in Diagn. Microbiol. Infect. Dis. 2009; 65 (4): 414-426

Case report of Aurantimonas altamirensis bloodstream infection. by Mendes RE, Denys GA, Fritsche TR and Jones RN published in J. Clin. Microbiol. 2009; 47 (2): 514-515

Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals. by Sader HS, Jones RN, Rossi KL and Rybak MJ published in J. Antimicrob. Chemother. 2009; 64 (5): 1024-1028

Daptomycin activity tested against linezolid-nonsusceptible Gram-positive clinical isolates. by Mendes RE, Jones RN, Deshpande LM, Ross JE, Sader HS published in Microb. Drug. Resist. 2009; 15 (4); 245-249

Expanded studies of piperacillin/tazobactam formulations: Variations among branded product lots and assessment of 46 generic lots. by Moet GJ, Watters AA, Sader HS and Jones RN published in Diagn. Microb. Infect. Dis. 2009; 65 (3): 319-322

Activity of daptomycin against Gram-positive bacterial isolates from Indian medical centres (2006-2007). by Mathai D, Biedenbach DJ, Jones RN, Bell JM, Turnidge JD and Sader HS published in Int. J. Antimicrob. Agents 2009; 34 (5): 497-499

Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus arueus. by Sader HS, Rhomberg PR and Jones RN published in Antimicrob. Agents Chemother. 2009; 53 (7): 3162-3165

Complete sequence of p07-406, a 24,179-base-pair plasmid harboring the bla_VIM-7 Metallo-ß-lactamase gene in a Pseudomonas aeruginosa isolates from the United States. by Li H, Toleman MA, Bennett PM, Jones RN and Walsh TR published in Antimicrob. Agents Chemother. 2008; 52 (9): 3099-3105

Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitis. by Ambrose PG, Anon JB, Bhavnani SM, Okusanya OO, Jones RN, Paglia MR, Kahn J and Drusano GL published in Diagn. Microbiol. Infect. Dis. 2008; 61 (1): 13-20

Proposed quality control ranges for 2-µg anidulafungin disk diffusion testing and ability of the method to detect strains with elevated echinocandin MIC values. by Jones RN, Ross JE and Sheehan DJ published in Diagnost Microbiol Infect Dis 2008; 62 (4): 474-477

Antimicrobial activity of DC-159a, a new fluroquinolone, against 1,149 recently collected clinical isolates. by Jones RN, Fritsche TR and Sader HS published in Antimicrob. Agents Chemother. 2008; 52 (10): 3763-3775

Zabofloxacin (DW-224a) activity against Neisseria gonorrhoeae including quinolone-resistant strains. by Jones RN, Biedenbach DJ, Ambrose PG and Wikler MA published in Diagn. Microbiol. Infect. Dis. 2008; 62 (1): 110-112

Key considerations in the treatment of complicated staphylococcal infections. by Jones RN published in Clin. Microbiol. Infect. 2008; 14 (Suppl 2): 3-9

Tigecycline activity tested against 11,808 bacterial pathogens recently collected from US medical centers. by Gales AC, Sader HS and Fritsche TR published in Diagn. Microbiol. Infect. Dis. 2008; 60 (4): 421-427

Antimicrobial susceptibility profile of contemporary clinical strains of Stenotrophomonas maltophilia isolates: Can moxifloxacin activity be predicted by levofloxacin MIC results?. by Gales AC, Jones RN and Sader HS published in J. Chemother. 2008; 20 (1): 38-42

Detection of methyltransferases conferring high-level resistance to aminoglycosides in Enterobacteriaceae from Europe, North America, and Latin America. by Fritsche TR, Castanheira M, Miller GH, Jones RN and Armstrong ES published in Antimicrob. Agents Chemother. 2008; 52 (5): 1843-1845